Verastem Oncology
VSTM
#6938
Rank
โ‚น52.90 B
Marketcap
โ‚น702.42
Share price
-1.02%
Change (1 day)
42.68%
Change (1 year)

Market capitalization of Verastem Oncology (VSTM)

Market cap: โ‚น52.90 Billion

As of January 2026 Verastem Oncology has a market cap of โ‚น52.90 Billion. This makes Verastem Oncology the world's 6938th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Verastem Oncology from 2012 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น52.90 B-2.92%
2025โ‚น54.49 B284.73%
2024โ‚น14.16 B-17.27%
2023โ‚น17.12 B144.7%
2022โ‚น6.99 B-74.83%
2021โ‚น27.79 B5.11%
2020โ‚น26.44 B245.45%
2019โ‚น7.65 B-55.85%
2018โ‚น17.33 B75.04%
2017โ‚น9.90 B251.86%
2016โ‚น2.81 B-38.34%
2015โ‚น4.56 B-71.08%
2014โ‚น15.79 B-11.48%
2013โ‚น17.83 B82.01%
2012โ‚น9.80 B

End of Day market cap according to different sources

On Jan 9th, 2026 the market cap of Verastem Oncology was reported to be:

โ‚น46.90 Billion
by Nasdaq info icon info icon
โ‚น52.90 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Curis
CRIS
โ‚น0.96 B-98.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น13.063 T 24,590.92%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
โ‚น1.886 T 3,466.38%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚น9.182 T 17,256.97%๐Ÿ‡ฌ๐Ÿ‡ง UK